Single‐cell mass cytometry adapted to measurements of the cell cycle
Mass cytometry is a recently introduced technology that utilizes transition element isotope‐tagged antibodies for protein detection on a single‐cell basis. By circumventing the limitations of emission spectral overlap associated with fluorochromes utilized in traditional flow cytometry, mass cytomet...
Saved in:
Published in | Cytometry. Part A Vol. 81A; no. 7; pp. 552 - 566 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.07.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Mass cytometry is a recently introduced technology that utilizes transition element isotope‐tagged antibodies for protein detection on a single‐cell basis. By circumventing the limitations of emission spectral overlap associated with fluorochromes utilized in traditional flow cytometry, mass cytometry currently allows measurement of up to 40 parameters per cell. Recently, a comprehensive mass cytometry analysis was described for the hematopoietic differentiation program in human bone marrow from a healthy donor. The current study describes approaches to delineate cell cycle stages utilizing 5‐iodo‐2‐deoxyuridine (IdU) to mark cells in S phase, simultaneously with antibodies against cyclin B1, cyclin A, and phosphorylated histone H3 (S28) that characterize the other cell cycle phases. Protocols were developed in which an antibody against phosphorylated retinoblastoma protein (Rb) at serines 807 and 811 was used to separate cells in G0 and G1 phases of the cell cycle. This mass cytometry method yielded cell cycle distributions of both normal and cancer cell populations that were equivalent to those obtained by traditional fluorescence cytometry techniques. We applied this to map the cell cycle phases of cells spanning the hematopoietic hierarchy in healthy human bone marrow as a prelude to later studies with cancers and other disorders of this lineage. © 2012 International Society for Advancement of Cytometry |
---|---|
AbstractList | Mass cytometry is a recently introduced technology that utilizes transition element isotope-tagged antibodies for protein detection on a single-cell basis. By circumventing the limitations of emission spectral overlap associated with fluorochromes utilized in traditional flow cytometry, mass cytometry currently allows measurement of up to 40 parameters per cell. Recently, a comprehensive mass cytometry analysis was described for the hematopoietic differentiation program in human bone marrow from a healthy donor. The current study describes approaches to delineate cell cycle stages utilizing 5-iodo-2-deoxyuridine (IdU) to mark cells in S phase, simultaneously with antibodies against cyclin B1, cyclin A, and phosphorylated histone H3 (S28) that characterize the other cell cycle phases. Protocols were developed in which an antibody against phosphorylated retinoblastoma protein (Rb) at serines 807 and 811 was used to separate cells in G0 and G1 phases of the cell cycle. This mass cytometry method yielded cell cycle distributions of both normal and cancer cell populations that were equivalent to those obtained by traditional fluorescence cytometry techniques. We applied this to map the cell cycle phases of cells spanning the hematopoietic hierarchy in healthy human bone marrow as a prelude to later studies with cancers and other disorders of this lineage. Abstract Mass cytometry is a recently introduced technology that utilizes transition element isotope‐tagged antibodies for protein detection on a single‐cell basis. By circumventing the limitations of emission spectral overlap associated with fluorochromes utilized in traditional flow cytometry, mass cytometry currently allows measurement of up to 40 parameters per cell. Recently, a comprehensive mass cytometry analysis was described for the hematopoietic differentiation program in human bone marrow from a healthy donor. The current study describes approaches to delineate cell cycle stages utilizing 5‐iodo‐2‐deoxyuridine (IdU) to mark cells in S phase, simultaneously with antibodies against cyclin B1, cyclin A, and phosphorylated histone H3 (S28) that characterize the other cell cycle phases. Protocols were developed in which an antibody against phosphorylated retinoblastoma protein (Rb) at serines 807 and 811 was used to separate cells in G0 and G1 phases of the cell cycle. This mass cytometry method yielded cell cycle distributions of both normal and cancer cell populations that were equivalent to those obtained by traditional fluorescence cytometry techniques. We applied this to map the cell cycle phases of cells spanning the hematopoietic hierarchy in healthy human bone marrow as a prelude to later studies with cancers and other disorders of this lineage. © 2012 International Society for Advancement of Cytometry Mass cytometry is a recently introduced technology that utilizes transition element isotope‐tagged antibodies for protein detection on a single‐cell basis. By circumventing the limitations of emission spectral overlap associated with fluorochromes utilized in traditional flow cytometry, mass cytometry currently allows measurement of up to 40 parameters per cell. Recently, a comprehensive mass cytometry analysis was described for the hematopoietic differentiation program in human bone marrow from a healthy donor. The current study describes approaches to delineate cell cycle stages utilizing 5‐iodo‐2‐deoxyuridine (IdU) to mark cells in S phase, simultaneously with antibodies against cyclin B1, cyclin A, and phosphorylated histone H3 (S28) that characterize the other cell cycle phases. Protocols were developed in which an antibody against phosphorylated retinoblastoma protein (Rb) at serines 807 and 811 was used to separate cells in G0 and G1 phases of the cell cycle. This mass cytometry method yielded cell cycle distributions of both normal and cancer cell populations that were equivalent to those obtained by traditional fluorescence cytometry techniques. We applied this to map the cell cycle phases of cells spanning the hematopoietic hierarchy in healthy human bone marrow as a prelude to later studies with cancers and other disorders of this lineage. © 2012 International Society for Advancement of Cytometry Mass cytometry is a recently introduced technology that utilizes transition element isotope-tagged antibodies for protein detection on a single-cell basis. By circumventing the limitations of emission spectral overlap associated with fluorochromes utilized in traditional flow cytometry, mass cytometry currently allows measurement of up to 40 parameters per cell. Recently, a comprehensive mass cytometry analysis was described for the hematopoietic differentiation program in human bone marrow from a healthy donor. The current study describes approaches to delineate cell cycle stages utilizing 5-iodo-2-deoxyuridine (IdU) to mark cells in S phase, simultaneously with antibodies against cyclin B1, cyclin A, and phosphorylated histone H3 (S28) that characterize the other cell cycle phases. Protocols were developed in which an antibody against phosphorylated retinoblastoma protein (Rb) at serines 807 and 811 was used to separate cells in G0 and G1 phases of the cell cycle. This mass cytometry method yielded cell cycle distributions of both normal and cancer cell populations that were equivalent to those obtained by traditional fluorescence cytometry techniques. We applied this to map the cell cycle phases of cells spanning the hematopoietic hierarchy in healthy human bone marrow as a prelude to later studies with cancers and other disorders of this lineage. copyright 2012 International Society for Advancement of Cytometry |
Author | Fantl, Wendy J. Nolan, Garry P. Clutter, Matthew R. Behbehani, Gregory K. Bendall, Sean C. |
Author_xml | – sequence: 1 givenname: Gregory K. surname: Behbehani fullname: Behbehani, Gregory K. – sequence: 2 givenname: Sean C. surname: Bendall fullname: Bendall, Sean C. – sequence: 3 givenname: Matthew R. surname: Clutter fullname: Clutter, Matthew R. – sequence: 4 givenname: Wendy J. surname: Fantl fullname: Fantl, Wendy J. – sequence: 5 givenname: Garry P. surname: Nolan fullname: Nolan, Garry P. email: gnolan@stanford.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22693166$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkLtOwzAUQC1URB-wMSOPDKQ4duwkI6ooIFXqQBmYLMe-hqA8SpwIZeMT-Ea-hKQpHWHytXR8dH2maFSUBSB07pO5Twi91m1dztWcUhLyIzTxOadeEDMyOsyUjtHUuTdCGCeMnqAxpSJmvhATtHxMi5cMvj-_NGQZzpVzuDfmUFctVkZtazC4LnEOyjUV5FDUDpcW16-Ad090qzM4RcdWZQ7O9ucMPS1vN4t7b7W-e1jcrDwdhJR7yk-4iJThLNYi4CYwMTMaTGRVnDAmrE4YNzShCiDUgkSRFcRaDmHS3QOfzdDl4N1W5XsDrpZ56vo1VAFl46Tf_VawkEbsf5RQSnkXJ-jQqwHVVelcBVZuqzRXVdtBso8s-yRSyV3kDr_Ym5skB3OAf6t2ABuAjzSD9k-ZXDxv1oP2B8sxi6o |
CitedBy_id | crossref_primary_10_1002_1873_3468_12712 crossref_primary_10_1038_s41385_018_0047_y crossref_primary_10_1038_s41467_018_07333_4 crossref_primary_10_1016_j_bbapap_2015_01_008 crossref_primary_10_1002_cyto_a_22894 crossref_primary_10_1038_s41418_020_0498_z crossref_primary_10_26508_lsa_201900554 crossref_primary_10_1002_cyto_a_23621 crossref_primary_10_1002_cyto_a_22498 crossref_primary_10_1038_s41596_018_0016_7 crossref_primary_10_3390_ijms160818878 crossref_primary_10_1016_j_leukres_2020_106404 crossref_primary_10_1038_s41587_020_0651_8 crossref_primary_10_1038_s41598_021_91816_w crossref_primary_10_1016_j_csbj_2020_03_024 crossref_primary_10_1038_s41593_022_01181_8 crossref_primary_10_1186_s12865_017_0192_1 crossref_primary_10_1002_adhm_202201846 crossref_primary_10_1002_ctm2_206 crossref_primary_10_1002_cyto_a_22778 crossref_primary_10_1016_j_trac_2023_117257 crossref_primary_10_1038_ncb3507 crossref_primary_10_1002_eji_201646632 crossref_primary_10_1002_cyto_a_22648 crossref_primary_10_1097_ACI_0000000000000319 crossref_primary_10_1021_acs_analchem_2c04165 crossref_primary_10_1038_s41467_022_34653_3 crossref_primary_10_2139_ssrn_3869896 crossref_primary_10_1039_D3AN00370A crossref_primary_10_1158_1541_7786_MCR_22_0109 crossref_primary_10_1189_jlb_1112571 crossref_primary_10_1002_adhm_202202422 crossref_primary_10_1016_j_cell_2017_07_024 crossref_primary_10_1093_mtomcs_mfac085 crossref_primary_10_1002_adma_202008297 crossref_primary_10_1038_s41467_019_09128_7 crossref_primary_10_1073_pnas_2115567119 crossref_primary_10_1002_cpim_31 crossref_primary_10_1021_acs_chemrev_2c00350 crossref_primary_10_1002_cyto_a_23283 crossref_primary_10_1007_s00216_017_0310_1 crossref_primary_10_1002_cyto_a_23960 crossref_primary_10_1002_cyto_a_24016 crossref_primary_10_1016_j_tig_2015_07_003 crossref_primary_10_1111_febs_14730 crossref_primary_10_1021_acs_analchem_0c03908 crossref_primary_10_1038_s41598_022_04842_7 crossref_primary_10_1016_j_celrep_2023_113293 crossref_primary_10_1021_acsnanoscienceau_3c00001 crossref_primary_10_1038_s41592_020_0737_8 crossref_primary_10_1016_j_aca_2014_02_033 crossref_primary_10_1038_s41418_018_0167_7 crossref_primary_10_1016_j_omton_2024_200820 crossref_primary_10_1158_2159_8290_CD_15_0298 crossref_primary_10_1016_j_cll_2021_03_008 crossref_primary_10_1021_jacs_6b12822 crossref_primary_10_1038_nbt_2283 crossref_primary_10_1038_s41392_023_01380_0 crossref_primary_10_1124_dmd_114_060798 crossref_primary_10_1189_jlb_6RU0115_020R crossref_primary_10_3390_cells12162045 crossref_primary_10_1016_j_tcb_2022_01_012 crossref_primary_10_1002_cpcy_25 crossref_primary_10_1002_cyto_a_23793 crossref_primary_10_1049_iet_syb_2016_0016 crossref_primary_10_1093_infdis_jiac500 crossref_primary_10_1016_j_copbio_2014_07_004 crossref_primary_10_1002_anie_201405233 crossref_primary_10_1002_cyto_a_23799 crossref_primary_10_1039_C9EN01104H crossref_primary_10_1002_mas_21391 crossref_primary_10_1074_mcp_R119_001790 crossref_primary_10_1021_acs_analchem_8b02790 crossref_primary_10_1177_2472630319834057 crossref_primary_10_15252_emmm_202013144 crossref_primary_10_1371_journal_pcbi_1003806 crossref_primary_10_1002_cyto_a_22573 crossref_primary_10_1016_j_cell_2016_04_019 crossref_primary_10_3109_10408363_2012_738808 crossref_primary_10_1038_s41467_020_17186_5 crossref_primary_10_1039_C7LC00546F crossref_primary_10_1002_cyto_a_22336 crossref_primary_10_1016_j_vaccine_2015_06_117 crossref_primary_10_1021_acs_bioconjchem_9b00559 crossref_primary_10_1002_eji_201970107 crossref_primary_10_1039_D0JA00194E crossref_primary_10_1016_j_biologicals_2013_08_006 crossref_primary_10_1016_j_cels_2018_02_010 crossref_primary_10_1002_ange_201405233 crossref_primary_10_3389_fimmu_2020_578176 crossref_primary_10_1016_j_stem_2015_01_015 crossref_primary_10_1002_1873_3468_12231 crossref_primary_10_1021_acs_analchem_9b00198 crossref_primary_10_1186_s40425_016_0107_3 crossref_primary_10_15252_msb_202110402 crossref_primary_10_1111_cpr_12050 crossref_primary_10_1186_s13045_017_0401_7 crossref_primary_10_1371_journal_pone_0079987 crossref_primary_10_1021_acs_analchem_5b04749 crossref_primary_10_1080_15476286_2017_1327510 crossref_primary_10_1021_acs_analchem_9b04970 crossref_primary_10_1039_D2NR06020E crossref_primary_10_1002_cyto_b_21860 crossref_primary_10_1016_j_crmeth_2022_100238 crossref_primary_10_1021_acs_analchem_2c00795 crossref_primary_10_1002_cyto_a_22285 crossref_primary_10_1038_s41598_017_03610_2 crossref_primary_10_1002_cyto_a_22323 crossref_primary_10_1126_sciadv_ade9238 crossref_primary_10_1002_cyto_a_23495 crossref_primary_10_1016_j_crmeth_2022_100236 crossref_primary_10_1016_j_isci_2022_105826 crossref_primary_10_1186_s13059_014_0525_9 crossref_primary_10_1038_s41584_019_0338_z crossref_primary_10_1007_s00018_023_04772_1 crossref_primary_10_1371_journal_pcbi_1003365 crossref_primary_10_1007_s00216_016_0075_y crossref_primary_10_1039_C4LC00795F crossref_primary_10_1016_j_cell_2023_11_005 crossref_primary_10_1002_cyto_b_21502 crossref_primary_10_1016_j_coi_2013_07_004 crossref_primary_10_1186_s12915_021_01138_6 crossref_primary_10_1039_C7AN01346A crossref_primary_10_1002_cyto_a_23521 crossref_primary_10_1002_cyto_a_24852 crossref_primary_10_1016_j_cll_2017_07_010 crossref_primary_10_1016_j_advms_2019_12_001 crossref_primary_10_1152_ajpheart_00514_2021 crossref_primary_10_1038_s41596_021_00603_4 crossref_primary_10_1002_cyto_a_22799 crossref_primary_10_1002_cbic_202000369 crossref_primary_10_1126_scitranslmed_aac5722 crossref_primary_10_1073_pnas_1806695115 crossref_primary_10_1002_cyto_a_23929 crossref_primary_10_1038_s41556_020_0474_3 crossref_primary_10_1021_acs_analchem_2c01509 crossref_primary_10_1038_nprot_2016_089 crossref_primary_10_1074_jbc_RA119_009061 crossref_primary_10_1039_D3JA00412K crossref_primary_10_1038_s41598_022_16616_2 crossref_primary_10_1007_s00216_014_8143_7 crossref_primary_10_1002_cyto_a_23630 crossref_primary_10_1038_s41467_018_03005_5 crossref_primary_10_1002_smll_201907674 crossref_primary_10_1021_acs_analchem_0c03560 crossref_primary_10_1002_cyto_a_22268 crossref_primary_10_3389_fimmu_2018_01672 crossref_primary_10_1038_s41598_018_25000_y crossref_primary_10_1371_journal_pone_0131722 crossref_primary_10_1016_j_cbpa_2020_12_005 |
Cites_doi | 10.1038/nbt.1991 10.1016/S0092-8674(04)00300-9 10.1002/cyto.a.20003 10.1016/j.jim.2005.09.020 10.1002/0471142956.cy0724s28 10.1007/978-1-61737-950-5_11 10.1002/0471142956.cy0703s30 10.1084/jem.20050967 10.1039/b710510j 10.1101/sqb.2008.73.031 10.1021/ac702128m 10.1073/pnas.96.6.3120 10.1369/jhc.4A6285.2004 10.1186/1471-2105-10-106 10.1126/science.1198704 10.1182/blood.V68.6.1185.1185 10.2353/ajpath.2006.060312 10.1002/0471142956.cy1017s53 10.1158/1078-0432.CCR-09-0787 10.1182/blood.V56.3.361.361 10.1021/ac901049w 10.1002/cyto.a.20252 10.1046/j.1356-9597.2001.00498.x 10.1002/(SICI)1097-0320(19960901)25:1<1::AID-CYTO1>3.0.CO;2-N 10.1182/blood.V44.1.1.1 10.1089/scd.2007.0017 10.1182/blood-2005-06-2325 |
ContentType | Journal Article |
Copyright | Copyright © 2012 International Society for Advancement of Cytometry Copyright © 2012 International Society for Advancement of Cytometry. |
Copyright_xml | – notice: Copyright © 2012 International Society for Advancement of Cytometry – notice: Copyright © 2012 International Society for Advancement of Cytometry. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7QO 8FD FR3 P64 RC3 |
DOI | 10.1002/cyto.a.22075 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Biotechnology Research Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic Genetics Abstracts Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | MEDLINE CrossRef Genetics Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1552-4930 |
EndPage | 566 |
ExternalDocumentID | 10_1002_cyto_a_22075 22693166 CYTO22075 |
Genre | article Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: Rachford and Carlota A. Harris Endowed Professorship – fundername: Stanford Cancer Center – fundername: Bill and Melinda Gates Foundation funderid: GF12141‐137101 – fundername: NIH/NCI funderid: U19 AI057229; P01 CA034233; HHSN272200700038C; 1R01CA130826; NCI RFA CA 09‐011; NHLBI‐HV‐10‐05(2); CIRM DR1‐01477; RB2‐01592 – fundername: European Commission funderid: HEALTH.2010.1.2‐1 – fundername: NCI NIH HHS grantid: R01 CA130826 – fundername: NHLBI NIH HHS grantid: HHSN268201000034C – fundername: NCI NIH HHS grantid: U54 CA149145 – fundername: NIAID NIH HHS grantid: T32 AI007290 – fundername: NIAID NIH HHS grantid: HHSN272200700038C – fundername: NCI NIH HHS grantid: P01 CA034233 – fundername: NCI NIH HHS grantid: CA034233 – fundername: NCI NIH HHS grantid: CA 09011 – fundername: NIAID NIH HHS grantid: U19 AI057229 – fundername: NCI NIH HHS grantid: 1R01CA130826 |
GroupedDBID | --- -~X .3N .GA .Y3 05W 0R~ 10A 1L6 1OC 24P 2WC 31~ 33P 3SF 4.4 4ZD 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABLJU ABPVW ACAHQ ACCFJ ACCZN ACFBH ACGFS ACIWK ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AUFTA AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CO8 CS3 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRSTM DU5 E3Z EBD EBS EJD EMOBN F00 F01 F04 F5P G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 P2P P2W P2X P4D Q.N QB0 QRW R.K RNS ROL RWI SUPJJ SV3 UB1 V2E W8V W99 WBKPD WIH WIK WIN WJL WNSPC WOHZO WQJ WRC WXSBR WYISQ XG1 XV2 ZZTAW ~IA ~KM ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7QO 8FD FR3 P64 RC3 |
ID | FETCH-LOGICAL-c4725-a1b568ad539c645d4d93dced8fa9b336fcb35d2b2aee7c6088f60ff5e7be7c413 |
IEDL.DBID | DR2 |
ISSN | 1552-4922 |
IngestDate | Sat Aug 17 02:22:15 EDT 2024 Sat Aug 17 01:09:49 EDT 2024 Fri Aug 23 02:59:15 EDT 2024 Sat Sep 28 07:55:28 EDT 2024 Sat Aug 24 00:42:11 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
License | Copyright © 2012 International Society for Advancement of Cytometry. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4725-a1b568ad539c645d4d93dced8fa9b336fcb35d2b2aee7c6088f60ff5e7be7c413 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://europepmc.org/articles/pmc3667754?pdf=render |
PMID | 22693166 |
PQID | 1022259224 |
PQPubID | 23479 |
PageCount | 15 |
ParticipantIDs | proquest_miscellaneous_1492637283 proquest_miscellaneous_1022259224 crossref_primary_10_1002_cyto_a_22075 pubmed_primary_22693166 wiley_primary_10_1002_cyto_a_22075_CYTO22075 |
PublicationCentury | 2000 |
PublicationDate | July 2012 |
PublicationDateYYYYMMDD | 2012-07-01 |
PublicationDate_xml | – month: 07 year: 2012 text: July 2012 |
PublicationDecade | 2010 |
PublicationPlace | Hoboken |
PublicationPlace_xml | – name: Hoboken – name: United States |
PublicationTitle | Cytometry. Part A |
PublicationTitleAlternate | Cytometry A |
PublicationYear | 2012 |
Publisher | Wiley Subscription Services, Inc., A Wiley Company |
Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company |
References | 2006; 69A 2011; 699 2010; 16 2009; 81 2011 2010 1997; 25 2002; 7 2004 2008; 73 2011; 332 2004; 58A 2007; 16 2004; 52 1974; 44 2011; 108 2009; 10 2006; 308 2004; 60B 2005; 202 1986; 68 1980; 56 2008; 23 1999; 96 1996; 25 2006; 107 2011; 29 2004; 117 2008; 80 2006; 169 1994; 54 21757645 - Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12845-50 10077647 - Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3120-5 20145169 - Clin Cancer Res. 2010 Feb 15;16(4):1094-9 16336974 - J Immunol Methods. 2006 Jan 20;308(1-2):68-76 16538653 - Cytometry A. 2006 Apr;69(4):249-59 19122859 - J Anal At Spectrom. 2008;23(4):463-469 21116986 - Methods Mol Biol. 2011;699:229-49 15084261 - Cell. 2004 Apr 16;117(2):239-51 16877336 - Am J Pathol. 2006 Aug;169(2):338-46 18318509 - Anal Chem. 2008 Apr 1;80(7):2539-47 21551058 - Science. 2011 May 6;332(6030):687-96 15221864 - Cytometry B Clin Cytom. 2004 Jul;60(1):1-13 4525505 - Blood. 1974 Jul;44(1):1-18 3535923 - Blood. 1986 Dec;68(6):1185-95 9197332 - Exp Hematol. 1997 Jun;25(6):530-5 11856369 - Genes Cells. 2002 Jan;7(1):11-7 19022770 - Cold Spring Harb Symp Quant Biol. 2008;73:439-49 16234360 - Blood. 2006 Feb 1;107(3):1166-73 8875049 - Cytometry. 1996 Sep 1;25(1):1-13 14994216 - Cytometry A. 2004 Mar;58(1):21-32 16330818 - J Exp Med. 2005 Dec 5;202(11):1599-611 18770805 - Curr Protoc Cytom. 2004 Nov;Chapter 7:Unit 7.3 17999593 - Stem Cells Dev. 2007 Oct;16(5):707-17 6931620 - Blood. 1980 Sep;56(3):361-7 19358741 - BMC Bioinformatics. 2009;10:106 8044772 - Cancer Res. 1994 Aug 15;54(16):4285-8 19601617 - Anal Chem. 2009 Aug 15;81(16):6813-22 18770801 - Curr Protoc Cytom. 2004 May;Chapter 7:Unit 7.24 15505345 - J Histochem Cytochem. 2004 Nov;52(11):1503-9 22692796 - Cytometry A. 2012 Jul;81(7):546-8 22046573 - Bone Marrow Res. 2011;2011:950934 20578106 - Curr Protoc Cytom. 2010 Jul;Chapter 10:Unit10.17 21964415 - Nat Biotechnol. 2011 Oct;29(10):886-91 e_1_2_9_30_2 e_1_2_9_12_2 e_1_2_9_11_2 Moore MA (e_1_2_9_8_2) 1974; 44 Raza A (e_1_2_9_9_2) 1997; 25 Preisler H (e_1_2_9_33_2) 1980; 56 e_1_2_9_14_2 e_1_2_9_16_2 e_1_2_9_15_2 e_1_2_9_18_2 e_1_2_9_17_2 Pearce DJ (e_1_2_9_10_2) 2006; 107 e_1_2_9_19_2 Griffin J (e_1_2_9_7_2) 1986; 68 van Lochem EG (e_1_2_9_13_2) 2004; 60 e_1_2_9_21_2 e_1_2_9_20_2 e_1_2_9_23_2 e_1_2_9_22_2 Gong J (e_1_2_9_28_2) 1994; 54 e_1_2_9_6_2 e_1_2_9_5_2 e_1_2_9_4_2 e_1_2_9_3_2 e_1_2_9_2_2 Passegue E (e_1_2_9_31_2) 2005; 202 Head DR (e_1_2_9_32_2) 2011 e_1_2_9_25_2 e_1_2_9_24_2 e_1_2_9_26_2 (e_1_2_9_27_2) 2011; 108 e_1_2_9_29_2 |
References_xml | – volume: 308 start-page: 68–76 year: 2006 article-title: Multiple cellular antigen detection by ICP‐MS publication-title: J Immunol Methods – volume: 7 start-page: 11–17 year: 2002 article-title: Aurora‐B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation publication-title: Genes to Cells – volume: 10 start-page: 106 year: 2009 article-title: flowCore: A bioconductor package for high throughput flow cytometry publication-title: BMC Bioinformatics – year: 2010 article-title: Web‐based analysis and publication of flow cytometry experiments publication-title: Curr Protoc Cytom – volume: 60B start-page: 1–13 year: 2004 article-title: Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: Reference patterns for age‐related changes and disease‐induced shifts publication-title: Cytometry Part B: Clinical Cytometry – start-page: 2011 year: 2011 article-title: Innovative analyses support a role for DNA damage and an aberrant cell cycle in myelodysplastic syndrome pathogenesis publication-title: Bone Marrow Res – volume: 80 start-page: 2539–2547 year: 2008 article-title: Study of cell antigens and intracellular DNA by identification of element‐containing labels and metallointercalators using inductively coupled plasma mass spectrometry publication-title: Anal Chem – volume: 52 start-page: 1503–1509 year: 2004 article-title: Characterization of a monoclonal antibody, HTA28, recognizing a histone H3 phosphorylation site as a useful marker of M‐phase cells publication-title: J Histochem Cytochem – volume: 108 start-page: 12845–12850 year: 2011 article-title: Asymmetric cancer cell division regulated by AKT publication-title: Proc Natl Acad Sci – volume: 69A start-page: 249–259 year: 2006 article-title: Evaluation of intranuclear BrdU detection procedures for use in multicolor flow cytometry publication-title: Cytometry Part A – volume: 58A start-page: 21–32 year: 2004 article-title: Cytometry of the cell cycle: Cycling through history publication-title: Cytometry Part A – volume: 96 start-page: 3120–3125 year: 1999 article-title: In vivo proliferation and cell cycle kinetics of long‐term self‐renewing hematopoietic stem cells publication-title: Proc. Natl. Acad. Sci. USA – year: 2004 article-title: Detection of mitotic cells publication-title: Curr Protoc Cytom – volume: 16 start-page: 1094–1099 year: 2010 article-title: Targeting the RB‐pathway in cancer therapy publication-title: Clin Cancer Res – volume: 56 start-page: 361–367 year: 1980 article-title: Prediction of response to chemotherapy in acute myelocytic leukemia publication-title: Blood – volume: 699 start-page: 229–249 year: 2011 article-title: Multiparameter cell cycle analysis publication-title: Methods in molecular biology – volume: 117 start-page: 239–251 year: 2004 article-title: Cyclin C/Cdk3 promotes Rb‐dependent G0 Exit publication-title: Cell – volume: 25 start-page: 1–13 year: 1996 article-title: Cytometry of cyclin proteins publication-title: Cytometry – volume: 25 start-page: 530 year: 1997 article-title: Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo‐ and/or bromodeoxyuridine publication-title: Exp Hematol – volume: 68 start-page: 1185–1195 year: 1986 article-title: Clonogenic cells in acute myeloblastic leukemia publication-title: Blood – volume: 44 start-page: 1–18 year: 1974 article-title: Agar culture studies in 127 cases of untreated acute leukemia: The prognostic value of reclassification of leukemia according to in vitro growth characteristics publication-title: Blood – volume: 107 start-page: 1166–1173 year: 2006 article-title: AML engraftment in the NOD/SCID assay reflects the outcome of AML: Implications for our understanding of the heterogeneity of AML publication-title: Blood – volume: 23 start-page: 463–469 year: 2008 article-title: Development of analytical methods for multiplex bio‐assay with inductively coupled plasma mass spectrometry publication-title: J Anal At Spectrom – volume: 29 start-page: 886–891 year: 2011 article-title: Extracting a cellular hierarchy from high‐dimensional cytometry data with SPADE publication-title: Nat Biotech – volume: 54 start-page: 4285–4288 year: 1994 article-title: Unscheduled expression of Cyclin B1 and Cyclin E in several leukemic and solid tumor cell lines publication-title: Cancer Res – year: 2004 article-title: Differential staining of DNA and RNA publication-title: Curr Protoc Cytom – volume: 169 start-page: 338–346 year: 2006 article-title: Hematopoietic stem cells: The paradigmatic tissue‐specific stem cell publication-title: Am J Pathol – volume: 73 start-page: 439–449 year: 2008 article-title: Establishment of a normal hematopoietic and leukemia stem cell hierarchy publication-title: Cold Spring Harb Symp Quant Biol – volume: 81 start-page: 6813–6822 year: 2009 article-title: Mass cytometry: Technique for real time single cell multitarget immunoassay based on inductively coupled plasma time‐of‐flight mass spectrometry publication-title: Anal Chem – volume: 332 start-page: 687–696 year: 2011 article-title: Single‐cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum publication-title: Science – volume: 202 start-page: 1599–1611 year: 2005 article-title: Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates publication-title: J Exp Med – volume: 16 start-page: 707–717 year: 2007 article-title: The effect of bleeding on hematopoietic stem cell cycling and self‐renewal publication-title: Stem Cells Dev – ident: e_1_2_9_6_2 doi: 10.1038/nbt.1991 – volume: 54 start-page: 4285–4288 year: 1994 ident: e_1_2_9_28_2 article-title: Unscheduled expression of Cyclin B1 and Cyclin E in several leukemic and solid tumor cell lines publication-title: Cancer Res contributor: fullname: Gong J – ident: e_1_2_9_16_2 doi: 10.1016/S0092-8674(04)00300-9 – ident: e_1_2_9_25_2 doi: 10.1002/cyto.a.20003 – ident: e_1_2_9_2_2 doi: 10.1016/j.jim.2005.09.020 – ident: e_1_2_9_18_2 doi: 10.1002/0471142956.cy0724s28 – ident: e_1_2_9_19_2 doi: 10.1007/978-1-61737-950-5_11 – ident: e_1_2_9_22_2 doi: 10.1002/0471142956.cy0703s30 – volume: 202 start-page: 1599–1611 year: 2005 ident: e_1_2_9_31_2 article-title: Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates publication-title: J Exp Med doi: 10.1084/jem.20050967 contributor: fullname: Passegue E – ident: e_1_2_9_3_2 doi: 10.1039/b710510j – ident: e_1_2_9_29_2 doi: 10.1101/sqb.2008.73.031 – ident: e_1_2_9_14_2 doi: 10.1021/ac702128m – ident: e_1_2_9_30_2 doi: 10.1073/pnas.96.6.3120 – volume: 60 start-page: 1–13 year: 2004 ident: e_1_2_9_13_2 article-title: Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: Reference patterns for age‐related changes and disease‐induced shifts publication-title: Cytometry Part B: Clinical Cytometry contributor: fullname: van Lochem EG – ident: e_1_2_9_21_2 doi: 10.1369/jhc.4A6285.2004 – ident: e_1_2_9_11_2 doi: 10.1186/1471-2105-10-106 – ident: e_1_2_9_5_2 doi: 10.1126/science.1198704 – volume: 68 start-page: 1185–1195 year: 1986 ident: e_1_2_9_7_2 article-title: Clonogenic cells in acute myeloblastic leukemia publication-title: Blood doi: 10.1182/blood.V68.6.1185.1185 contributor: fullname: Griffin J – ident: e_1_2_9_24_2 doi: 10.2353/ajpath.2006.060312 – start-page: 2011 year: 2011 ident: e_1_2_9_32_2 article-title: Innovative analyses support a role for DNA damage and an aberrant cell cycle in myelodysplastic syndrome pathogenesis publication-title: Bone Marrow Res contributor: fullname: Head DR – ident: e_1_2_9_12_2 doi: 10.1002/0471142956.cy1017s53 – ident: e_1_2_9_26_2 doi: 10.1158/1078-0432.CCR-09-0787 – volume: 56 start-page: 361–367 year: 1980 ident: e_1_2_9_33_2 article-title: Prediction of response to chemotherapy in acute myelocytic leukemia publication-title: Blood doi: 10.1182/blood.V56.3.361.361 contributor: fullname: Preisler H – ident: e_1_2_9_4_2 doi: 10.1021/ac901049w – ident: e_1_2_9_15_2 doi: 10.1002/cyto.a.20252 – ident: e_1_2_9_20_2 doi: 10.1046/j.1356-9597.2001.00498.x – ident: e_1_2_9_17_2 doi: 10.1002/(SICI)1097-0320(19960901)25:1<1::AID-CYTO1>3.0.CO;2-N – volume: 108 start-page: 12845–12850 year: 2011 ident: e_1_2_9_27_2 article-title: Asymmetric cancer cell division regulated by AKT publication-title: Proc Natl Acad Sci – volume: 44 start-page: 1–18 year: 1974 ident: e_1_2_9_8_2 article-title: Agar culture studies in 127 cases of untreated acute leukemia: The prognostic value of reclassification of leukemia according to in vitro growth characteristics publication-title: Blood doi: 10.1182/blood.V44.1.1.1 contributor: fullname: Moore MA – ident: e_1_2_9_23_2 doi: 10.1089/scd.2007.0017 – volume: 107 start-page: 1166–1173 year: 2006 ident: e_1_2_9_10_2 article-title: AML engraftment in the NOD/SCID assay reflects the outcome of AML: Implications for our understanding of the heterogeneity of AML publication-title: Blood doi: 10.1182/blood-2005-06-2325 contributor: fullname: Pearce DJ – volume: 25 start-page: 530 year: 1997 ident: e_1_2_9_9_2 article-title: Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo‐ and/or bromodeoxyuridine publication-title: Exp Hematol contributor: fullname: Raza A |
SSID | ssj0035032 |
Score | 2.4694908 |
Snippet | Mass cytometry is a recently introduced technology that utilizes transition element isotope‐tagged antibodies for protein detection on a single‐cell basis. By... Mass cytometry is a recently introduced technology that utilizes transition element isotope-tagged antibodies for protein detection on a single-cell basis. By... Abstract Mass cytometry is a recently introduced technology that utilizes transition element isotope‐tagged antibodies for protein detection on a single‐cell... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 552 |
SubjectTerms | Animals Antibodies Antibodies - chemistry Bone Marrow Cells - metabolism Bone Marrow Cells - physiology cell cycle Cell Cycle Checkpoints Cell Differentiation Cell Line Cell Proliferation Cell Separation Cyclin A - metabolism Cyclin B1 - metabolism DNA Replication Flow Cytometry Hematopoiesis Histones - metabolism Humans Immunophenotyping iododeoxyuridine mass cytometry Membrane Proteins - metabolism Mice retinoblastoma Retinoblastoma Protein - metabolism Single-Cell Analysis - methods Staining and Labeling T-Lymphocytes - metabolism T-Lymphocytes - physiology Transition Elements - chemistry |
Title | Single‐cell mass cytometry adapted to measurements of the cell cycle |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcyto.a.22075 https://www.ncbi.nlm.nih.gov/pubmed/22693166 https://search.proquest.com/docview/1022259224 https://search.proquest.com/docview/1492637283 |
Volume | 81A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8QwFA4iCF7cl3Ejgt7s6GRrexRxcEEFF9BTyHrRmYrTOYwnf4K_0V_iS9oZNxD01kKS5vVL8r48ku8htEWFbdmUqMSyVpYw7XmSZTZNFMDvnUqtiLkOz87F0Q07ueW3dcAt3IWp9CFGAbcwM-J6HSa40r3dD9FQMyiLpmoSAk4PluCgpRc40eVIPYryvZifLIiMJSwnpD73DtV3P1f-6pF-0MyvrDW6nfY0ksMOV6dN7pv9UjfN8zctx_9bNIOmakaK96shNIvGXHcOTVQ5KgfzqH0Fzu3Bvb28hhg_7gDZxqGJjiufBlhZ9QicFZcF7nxEG3u48BiYJY5VzADaXUA37cPrg6OkTr6QGJYSDmBpLjJlOc2NYNwym1NrnM28yjWlwhtNuSWaKOdSI2Cx8mLPe-5SDe_gGhfReLfoumWEhTLUEKGI9p4RprV1QFKEsiFtFmxXGmh7CIB8rDQ2ZKWmTGQwSCoZ_0kDbQ7RkTAJggmq64p-T1bbVoCY_VImSCPSFOhUAy1V0I6-Bhw0py0hGmgnAvRrN-TB3fVFfFr5W_FVNAl0qz7su4bGy6e-WwdKU-oNGLjHpxtx-L4DAv_0fg |
link.rule.ids | 315,786,790,1382,27955,27956,46327,46751 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LTtwwFL1qqVC7gUIfTF-4Et01A-NXkiWiHU1bHhIdJLoyfm7KTBBkFsOqn8A38iW9djIDtBJS1V0i2Y6d4-t7fGWfC7DBpOu5nOrM8V6RcRNEVhQuzzTCH7zOnUy5Dvf25eCIfz0Wx22e03gXptGHmAfcomWk9ToaeAxIb96ohtppXXV1l1L0eg_hEVq8iJb56XCuH8XEVspQFmXGMl5S2p58x_qbt2vf9Ul_Ec27vDU5nv4ynMy63Jw3-dmd1KZrL_9Qc_yPMT2FpZaUku1mFq3AAz9ehcUmTeX0GfS_o3879de_rmKYn4yQb5PYxMjX51OinT5D2krqioxuAo4XpAoEySVJVewU230OR_3Pw51B1uZfyCzPqUC8jJCFdoKVVnLhuCuZs94VQZeGMRmsYcJRQ7X3uZW4XgW5FYLwucF39I4vYGFcjf0aEKkts1RqakLglBvjPPIUqV3MnIU7lg58mCGgzhqZDdUIKlMVB6S0Sv-kA-9n8Ci0gzgEPfbV5EI1O1fEmN9TJqojshwZVQdeNtjOv4Y0tGQ9KTvwMSF0bzfUzo_hQXp69W_F1-HxYLi3q3a_7H97DU-QfbVnf9_AQn0-8W-R4dTmXZrFvwGFTvel |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bTxQxFD4RjMQXvKCyglITeWMWtreZeTTABhHQCCT41PT6IruzgdmH5cmf4G_0l3DamV1EExJ4m0naTs98bc_Xk_Y7AB-ZdD2XU5053isyboLIisLlmUb4g9e5kynX4eGR3Dvl-2firA24xbswjT7ELOAWZ0Zar-MEH7mweSMaaid11dVdStHpzcFjLhmNm6-d7zP5KCa2UoKyqDKW8ZLS9uA71t_8u_Ztl_Qfz7xNW5Pf6T8DNe1xc9zkZ3dcm669-kfM8eEmPYfFlpKST80YegGP_PAlPGmSVE6WoH-M3u3c__n1Owb5yQDZNolNDHx9MSHa6RGSVlJXZHATbrwkVSBILUmqYifY7is47e-ebO9lbfaFzPKcCkTLCFloJ1hpJReOu5I5610RdGkYk8EaJhw1VHufW4mrVZBbIQifG3xH3_ga5ofV0C8DkdoyS6WmJgROuTHOI0uR2sW8Wbhf6cD6FAA1akQ2VCOnTFU0SGmV_kkHPkzRUTgLogl66KvxpWr2rQgxv6NM1EZkOfKpDrxpoJ19DUloyXpSdmAjAXRnN9T2j5Ov6ent_YqvwcK3nb46-Hz0ZQWeIvVqD_6uwnx9MfbvkN7U5n0aw9exCPZU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Single%E2%80%90cell+mass+cytometry+adapted+to+measurements+of+the+cell+cycle&rft.jtitle=Cytometry.+Part+A&rft.au=Behbehani%2C+Gregory+K.&rft.au=Bendall%2C+Sean+C.&rft.au=Clutter%2C+Matthew+R.&rft.au=Fantl%2C+Wendy+J.&rft.date=2012-07-01&rft.issn=1552-4922&rft.eissn=1552-4930&rft.volume=81A&rft.issue=7&rft.spage=552&rft.epage=566&rft_id=info:doi/10.1002%2Fcyto.a.22075&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_cyto_a_22075 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-4922&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-4922&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-4922&client=summon |